SILEXION THERAPEUTICS CORP Increase Decrease In Operating Lease Liability
SILEXION THERAPEUTICS CORP (SLXN) reported Increase Decrease In Operating Lease Liability of -$7.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- SILEXION THERAPEUTICS CORP increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$7.00K, a 450.00% decline year-over-year.
- SILEXION THERAPEUTICS CORP increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$4.00K.
- SILEXION THERAPEUTICS CORP increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$4.00K.
- SILEXION THERAPEUTICS CORP increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$2.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.00K 10-Q · filed 2026-08-14 | -$11.00K 10-Q · filed 2026-08-14 | -$15.00K derived: sum of 3 quarters · filed 2026-08-14 | -$17.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$4.00K S-1/A · filed 2026-08-10 | -$8.00K derived: sum of 2 quarters · filed 2026-08-10 | -$10.00K derived: sum of 3 quarters · filed 2026-08-10 | -$8.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$4.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | -$6.00K derived: sum of 2 quarters · filed 2026-08-10 | -$4.00K derived: sum of 3 quarters · filed 2026-08-14 | -$5.00K S-1/A · filed 2026-08-10 |
| 2025-09-30 | -$2.00K 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | -$1.00K 10-Q · filed 2025-11-12 | -$18.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $2.00K 10-Q · filed 2026-08-14 | $1.00K 10-Q · filed 2026-08-14 | -$16.00K derived: sum of 3 quarters · filed 2026-08-14 | -$60.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$1.00K S-1/A · filed 2026-08-10 | -$18.00K derived: sum of 2 quarters · filed 2026-08-10 | -$62.00K derived: sum of 3 quarters · filed 2026-08-10 | -$60.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2024-12-31 | -$17.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | -$61.00K derived: sum of 2 quarters · filed 2026-08-10 | -$59.00K derived: sum of 3 quarters · filed 2026-08-10 | -$57.00K S-1/A · filed 2026-08-10 |
| 2024-09-30 | -$44.00K 10-Q · filed 2025-11-12 | -$42.00K derived: sum of 2 quarters · filed 2025-11-12 | -$40.00K 10-Q · filed 2025-11-12 | -$27.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $2.00K 10-Q · filed 2025-08-12 | $4.00K 10-Q · filed 2025-08-12 | $17.00K derived: sum of 3 quarters · filed 2025-08-20 | $15.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2024-03-31 | $2.00K 10-Q · filed 2025-05-13 | $15.00K derived: sum of 2 quarters · filed 2025-08-20 | $13.00K derived: sum of 3 quarters · filed 2025-08-20 | $11.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2023-12-31 | $13.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-08-20 | $11.00K derived: sum of 2 quarters · filed 2025-08-20 | $9.00K derived: sum of 3 quarters · filed 2025-08-20 | $6.00K 8-K · filed 2025-08-20 |
| 2023-09-30 | -$2.00K 10-Q · filed 2024-11-14 | -$4.00K derived: sum of 2 quarters · filed 2024-11-14 | -$7.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$2.00K 10-Q · filed 2024-08-29 | -$5.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |